Figure 7.
Pharmacokinetic profile of ziconotide in CSF following intranasal administration of ziconotide KP 407 without chitosan (▲), with chitosan (◆) and ziconotide solution with chitosan (■).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.